Comparison of the efficacy of azythromycin and roxithromycin in the treatment of acute purulent exacerbation of chronic obstructive pulmonary disease

M. D. Filipovic, S. S. Pljaskic-Kamenov, S. S. Cekic (Nis, Yugoslavia)

Source: Annual Congress 2001 - Treatment of LRTI
Session: Treatment of LRTI
Session type: Thematic Poster Session
Number: 925
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. D. Filipovic, S. S. Pljaskic-Kamenov, S. S. Cekic (Nis, Yugoslavia). Comparison of the efficacy of azythromycin and roxithromycin in the treatment of acute purulent exacerbation of chronic obstructive pulmonary disease. Eur Respir J 2001; 16: Suppl. 31, 925

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of azithromycin vs. ciprofloxacin in the treatment of patients with acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002

The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 295s
Year: 2005

Efficacy and safety of moxifloxacin in the outpatient treatment of exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018


Efficacy of lasolvan in the treatment of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006

The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Antibiotics in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009

Use of antibiotics in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009

Efficacy and safety of bacterial lysates in patients with chronic obstructive pulmonary disease and exacerbation
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Clinical evaluation of patients with acute exacerbation of chronic bronchitis treated emperically with telithromycin
Source: Eur Respir J 2004; 24: Suppl. 48, 638s
Year: 2004

Fenspiride efficacy in the treatment of chronic obstructive pulmonary disease
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017



Bacterial infection in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012

Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002

Pharmacodynamics of levofloxicin in patients with acute exacerbation of chronic bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 546s
Year: 2002

Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001

Azithromycin to prevent exacerbations of chronic obstructive pulmonary disease: a study in the real-world setting
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020


The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008



Comparative evaluation of fluoroquinolone efficiency in treatment of infectious acute attack of chronic obstructive bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 512s
Year: 2004